conference series LLC
Conference series LLC invites all the participants from all over the
world to attend the prestigious conference entitled 16th International
conference on Neurology and Neurocognitive disorders 2017 Scheduled to be held in between Oct 09-10 at London.
Neurocognitive
disorders 2017 will provide a Forum for exchange of Ideas and Authoritative
views by leading Scientists as well as Business leaders and Investors in this
exciting field. Outstanding Keynote speakers and well known leading Scientists
and experts from across the globe will be expected to share their knowledge. It
is a broad audience gathering for exploring various neurocognitive disorders
and their prevention and treatments.
Neurology is a branch of medicine dealing with disorders of the nervous system. Neurology deals with the diagnosis
and treatment of all categories of conditions and disease involving the central and peripheral nervous system (and
its subdivisions, the autonomic nervous
system and the somatic
nervous system); including their coverings, blood vessels, and all
effector tissue, such as muscle. Neurological practice relies heavily on the
field of neuroscience, which is the scientific study of
the nervous system.
Neurocognitive
disorders are a
group of conditions that frequently lead to impaired mental function Neurocognitive disorders most commonly occur in older
adults, but they can affect younger people as well. Reduced mental
function may include: problems with memory, changes in behaviour, difficulty
understanding language, and trouble performing daily activities
These symptoms may be caused by a neurodegenerative condition, such as
Alzheimer’s disease or dementia. Neurodegenerative diseases cause
the brain and nerves to deteriorate over time, resulting in a gradual loss of
neurological function. Neurocognitive disorders can also develop as a
result of brain trauma or substance abuse. Healthcare providers can usually
determine the underlying cause of neurocognitive disorders based on the
reported symptoms and the results of diagnostic tests. The cause and severity
of neurocognitive disorders can help healthcare providers determine the
best course of treatment.
Alzheimer’s
disease is the most common form of dementia accounting for 50% to 70% of all
cases. It mostly occurs in the older people who are 65 years and above.
Moreover, growing awareness level regarding its symptoms, such as partial
dementia, is projected to boost the demand. Currently, there are an estimated 4
million individuals with dementia in the USA with more than 100 000 deaths
annually .The global market for Alzheimer’s disease reached $10.2 billion in
2012. The market is expected to decrease to $9.5 billion in 2017 for a CAGR of
-1.5%.
The
Alzheimer's Association funds independent investigators worldwide, they have
awarded over $335 million to more than 2,250 projects. The global cost of
Alzheimer’s and dementia is estimated to be $605 billion, which is equivalent to 1% of the
entire world’s gross domestic product.
Aggregate Cost
of Care by Payer for Americans Age 65 and Older with Alzheimer‘s Disease and
Other Dementias: Medicare $113
Billion, Medicaid $41 Billion, Out of pocket $44
Billion, Other $29 Billion.
Dementia is widely considered the second most common
cause of dementia after Alzheimer's disease, accounting for 10 percent of
cases. Many experts believe that vascular dementia remains
underdiagnosed like Alzheimer's disease even though it's recognized as common.
The global market for treatments for syndromes of dementia and movement
disorders was valued at 10.5 billion in 2011 and should reach $11.1 billion in
2012. Total market value is expected to reach $16.7 billion in 2017 after
increasing at a five-year compound annual growth rate (CAGR) of 8.5% in 2009 to
700 peer reviewed journals by 2016. Conference series LLC open access journals
and conferences readers/online visitors also increased from 10,000 in 2009 to
30 million by 2016.
International Conference Series
organizes 3000 scientific meetings every year across America, Europe, Middle
East and Asia.